MedPath

Development of an Adaptive Treatment for Weight Loss in People With Prediabetes

Not Applicable
Completed
Conditions
PreDiabetes
Obesity
Interventions
Behavioral: Reduced Carbohydrate Diet
Behavioral: High Carbohydrate Diet
Registration Number
NCT04745572
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

This 16-week study will use an experimental approach called the Sequential Multiple Assignment Randomized Trial to help determine which combination and sequence of weight loss program features are most effective in people who are at risk for type 2 diabetes. Participants in the study will be initially randomized to consume either a high or reduced carbohydrate diet. After 4 weeks, participants will be identified as Responders (greater than or equal to 2.5% weight loss) or Non-Responders (less than 2.5% weight loss). Responders will continue with their initial randomized group for the remainder of the trial. Non-responders will be re-randomized to 2nd stage interventions of either including additional exercise counseling and training or beginning a time restricted eating protocol for the remainder of the trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • 18-75 years of age
  • BMI of 27 kg/m2 or greater
  • at risk for developing type 2 diabetes (prediabetes)
Exclusion Criteria
  • Pregnant, planning to become pregnant, or breastfeeding
  • uncontrolled hypo or hyperthyroidism

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Reduced Carbohydrate DietReduced Carbohydrate DietEnrollment in a group-based behavioral weight loss intervention based on the Diabetes Prevention Program curriculum with reduced carbohydrate diet plan.
High Carbohydrate DietHigh Carbohydrate DietEnrollment in a group-based behavioral weight loss intervention based on the Diabetes Prevention Program curriculum with high carbohydrate diet plan.
Primary Outcome Measures
NameTimeMethod
Changes in body weightweek 16 visit

Measured on digital scale at final visit.

Secondary Outcome Measures
NameTimeMethod
Change in glucoseweek 16 visit

Serum glucose will be measured in a fasted state.

Change in hemoglobin A1cweek 16 visit

A1c is a measure of average glucose over the previous 3 months.

Change in insulinweek 16 visit

Serum insulin will be measured in a fasted state.

Changes in QUICKI indexweek 16 visit

Predictor of insulin resistance that will be calculated from glucose and insulin measures

Trial Locations

Locations (1)

UAB Highlands Family and Community Medicine Clinic

🇺🇸

Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath